Publication of prospectus regarding Enzymatica’s rights issue
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. The prospectus for Enzymatica AB’s rights issue of around SEK 74.7 million (the “has been approved and registered by the Swedish Financial Supervisory Authority (Finansinspektionen). The prospectus can be obtained from Enzymatica and Erik Penser Bank and is available on Enzymatica’s website (www.enzymatica.se) and on Erik Penser Bank’s website (www.penser.